ArticleInfection and immunity2009

Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes.

Clifford Shone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.